Feb 19, 2026 First Group Leaders announced for new dedicated Parkinson's Research Centre In 2025, the UK DRI partnered with Parkinson’s UK to launch a new £10m research... Learn more First Group Leaders announced for new dedicated Parkinson's Research Centre
Jan 01, 2024 Why partner with the UK DRI? The UK DRI is central to a rich and connected dementia research ecosystem, and we... Learn more Why partner with the UK DRI?
Jan 01, 2024 Why join the UK DRI? By joining the UK DRI you’ll belong to a team of world-class researchers, technical specialists... Learn more Why join the UK DRI?
Search for keywords Condition ConditionAlzheimer's diseaseFrontotemporal dementiaHuntington's diseaseLewy body dementiaMild cognitive impairmentMotor neuron disease/ALSOther conditionsParkinson's diseaseVascular dementia Techniques TechniquesAdvanced microscopy & imagingAdvanced spectroscopyBioinformaticsBiophysical techniquesCRISPRDrug screeningElectrophysiologyEpigenomicsExperimental medicineFlow cytometryFluid biomarkersGenomicsHuman brain imagingLipidomicsMass spec-based proteomicsMetabolomicsMouse behaviourMouse in vivo imagingNext generation sequencingNon-mammalian animal modelsOptogeneticsRobotics & environmental sensingSingle cell / nucleus transcriptomicsSoftware developmentSpatial transcriptomicsStatistical modellingStem cells / iPSCsStructural biologyTranscranial brain stimulationViral-mediated expression Topic TopicAgeingBiomarkers & diagnosticsCare & Home technologyCell biology of neurons & gliaGeneticsImmune systemLifestyle & environmentMolecular mechanismsSleep & Circadian rhythmsSynapse & CircuitryTreatments & InterventionsVascular system Tiara Schwarze-Taufiq Research Assistant Learn more Tiara Schwarze-Taufiq Dr Christoph Schweingruber Senior Researcher Learn more Dr Christoph Schweingruber Dr Gregory Scott Group Leader UK Care Research & Technology at Imperial Improving care for patients with neurological conditions by studying the brain's electrical activity Learn more Dr Gregory Scott Dr Sowmya Sekizar Postdoctoral Researcher Learn more Dr Sowmya Sekizar Sashika Selvackadunco Events Manager Learn more Sashika Selvackadunco Dr Bhuvaneish Selvaraj Emerging Leader UK DRI at Edinburgh Using disruptive technologies to decipher the underlying mechanisms that lead to neuron degeneration in ALS Learn more Dr Bhuvaneish Selvaraj Dr Andrea Serio Group Leader UK DRI at King's Combining bioengineering, imaging, and stem cell modelling to better understand motor neuron disease and dementia Learn more Dr Andrea Serio Noah Shapiro PhD Student Learn more Noah Shapiro Prof David Sharp Centre Director & Research Division Lead UK Care Research & Technology at Imperial Using radical new approaches to assess the effects of dementia and improve the lives of people living with the condition Learn more Prof David Sharp Verity Sharpe People Operations Manager Learn more Verity Sharpe Prof Chris Shaw Group Leader UK DRI at King's Proteostatic mechanisms in FTD and ALS Learn more Prof Chris Shaw Dr Preethi Sheshadri Postdoctoral Researcher Learn more Dr Preethi Sheshadri Pagination First page First Previous page ‹ … Page 43 Page 44 Current page 45 Page 46 Page 47 … Next page › Last page Last
Dr Gregory Scott Group Leader UK Care Research & Technology at Imperial Improving care for patients with neurological conditions by studying the brain's electrical activity Learn more Dr Gregory Scott
Dr Bhuvaneish Selvaraj Emerging Leader UK DRI at Edinburgh Using disruptive technologies to decipher the underlying mechanisms that lead to neuron degeneration in ALS Learn more Dr Bhuvaneish Selvaraj
Dr Andrea Serio Group Leader UK DRI at King's Combining bioengineering, imaging, and stem cell modelling to better understand motor neuron disease and dementia Learn more Dr Andrea Serio
Prof David Sharp Centre Director & Research Division Lead UK Care Research & Technology at Imperial Using radical new approaches to assess the effects of dementia and improve the lives of people living with the condition Learn more Prof David Sharp
Prof Chris Shaw Group Leader UK DRI at King's Proteostatic mechanisms in FTD and ALS Learn more Prof Chris Shaw
